Beilstein J. Org. Chem. 2020, 16, 1296–1304.
β-CD (4.0 g, 3.52 mmol) in H2O (250 mL). The solution was 28.0 (t, 1C), 26.5 (t, 1C), 21.7 (t, 1C), 11.7 (t, 1C), signals for 2
sonicated for 15 min and then AN (10 mL, 152.6 mmol) was quaternary C-atoms were not observed; MS m/z (% relative in-
added. After sonicating for additional 15 min, the solution was tensity): 282 (100), 283 (18.4), 284 (1.6).
transferred to fifteen quartz test tubes (each containing 20 mL),
purged with N2 for 20 min and sealed. The solutions were irra- Preparative irradiation of phthalimide 3 with AN and
diated for 1 h in a Luzchem reactor using 8 lamps with the with β-CD
output at 300 nm. When the irradiation was completed, the irra- Phthalimide 3 (150 mg, 0.461 mmol) was dissolved in CH3CN
diated solutions were combined and extracted with pentane (3 × (100 mL) and this solution was added slowly to the solution of
50 mL), and then with CH2Cl2 (2 × 50 mL) and EtOAc (2 × β-CD (5.23 g, 4.61 mmol) in H2O (370 mL). The solution was
50 mL). The organic extracts were dried over anhydrous sonicated for 15 min and then AN (10 mL, 152.6 mmol) was
Na2SO4, and CH2Cl2 and EtOAc were combined. The solu- added. After sonicating for additional 15 min, the solution was
tions were filtered and the solvent was removed on a rotary transferred to twenty quartz test tubes (each containing ≈20
evaporator. The photoproducts were separated by chromatogra- mL), purged with N2 for 20 min and sealed. The solutions were
phy on semipreparative HPLC followed by preparative TLC irradiated for 4 h in a Luzchem reactor using 8 lamps with the
using 5% MeOH/10% Et2O/85% CH2Cl2 and 40% EtOAc/ output at 300 nm. When the irradiation was completed, the irra-
CH2Cl2 as eluent. Compound 6 (11 mg, 10%) was identified by diated solutions were combined and extracted with pentane (3 ×
comparison of the spectra with those from precedent literature 50 mL), and then with CH2Cl2 (2 × 50 mL) and EtOAc (2 ×
50 mL). The organic extracts were dried over anhydrous
Na2SO4, and CH2Cl2 and EtOAc were combined. The solu-
HPLC method: 0–10 min (25% H2O/MeOH), 10–30 min tions were filtered and the solvent was removed on a rotary
(25–0% H2O/MeOH), 30–40 min (MeOH), 40-45 min (0–25% evaporator. The photoproducts were separated by chromatogra-
H2O/MeOH).
phy on a column of silica gel using 2–10% MeOH/CH2Cl2 fol-
lowed by preparative TLC with 5% MeOH/DCM and 5%
9b'-Hydroxy-5'-oxo-1',2',5',9b'-tetrahydrospiro[cyclo- MeOH/10% Et2O/DCM. The separation afforded only products
hexane-1,3'-pyrrolo[2,1-a]isoindole]-1'-carbonitrile (7): 2 10, 12, 13, and 14, which were identified by comparison of the
mg (2%), oily crystals; 1H NMR (CD3OD, 600 MHz) δ 7.81 spectra with literature precedent [54].
(dd, J = 1.0, 7.6 Hz, 1H), 7.70 (dt, J = 1.3, 7.6 Hz, 1H), 7.65 (dt,
J = 1.3, 7.6 Hz, 1H), 7.48 (dd, J = 1.0, 7.6 Hz, 1H), 4.55 (br s, Preparative irradiation of phthalimide 3 with AN and
3H), 3.48–3.42 (m, 1H), 2.65–2.59 (m, 1H), 2.06–2.00 (m, 2H), without β-CD
1.86–1.78 (m, 2H), 1.53–1.27 (m, 7H); MS m/z (% relative in- A solution of phthalimide 3 (142 mg, 0.450 mmol) and AN
tensity): 282 (100), 283 (18.4), 284 (1.6).
(5 mL, 76.33 mmol) in CH3CN (100 mL) was poured to a
quartz Erlenmayer flask. The solution was purged with N2 for
1,3,4,4a,5,11a-Hexahydro-6H-dibenzo[b,e]azepine-6,11(2H)- 30 min and then irradiated for 20 h with continuous stirring.
dione (8): 4 mg (4%), oily crystals; 1H NMR (CD3OD, 300 After the irradiation, the solvent was removed on a rotary evap-
MHz) δ 7.83–7.77 (m, 1H), 7.71–7.61 (m, 2H), 7.55–7.49 (m, orator and the crude reaction mixture was chromatographed on
1H), 4.18 (d, J =2.4 Hz, 1H), 2.74–2.64 (m, 1H), 2.31–2.20 (m, a column of SiO2 with 0–10% MeOH/CH2Cl2 as eluent, fol-
1H), 1.97–1.84 (m, 5H), 1.47–1.34 (m, 1H); 13C NMR lowed by chromatography on a semipreparative HPLC with
(CD3OD, 75 MHz) δ 207.1 (s, 1C), 172.2 (s, 1C), 139.1 (s, 1C), 0–50% H2O/MeOH, 0.1% TFA as eluent, and finally by prepar-
133.3 (s, 1C), 133.2 (d, 1C), 133.1 (d, 1C), 130.0 (d, 1C), 128.8 ative TLC with 3% MeOH/CH2Cl2 as eluent.
(d, 1C), 57.3 (d, 1C), 49.7 (d, 1C), 30.1 (t, 1C), 26.2 (t, 1C),
23.7 (t, 1C), 21.3 (t, 1C); MS m/z (% relative intensity): 229 HPLC method: 0–5 min (35% H2O/MeOH, 0.1% TFA),
(100), 230 (15.1), 231 (1.1).
5–20 min (35–0% H2O/MeOH, 0.1% TFA), 20–25 min
(MeOH), 25–30 min (0−35% H2O/MeOH, 0.1% TFA).
1,6-Dioxo-1,4,5,6-tetrahydro-2H-spiro[benzo[c]azocine-3,1'-
cyclohexane]-5-carbonitrile (9): 3 mg (3%), oily crystals; 1H 9b'-Methyl-5'-oxo-1',2',5',9b'-tetrahydrospiro[adamantane-
NMR (CD3OD, 300 MHz) δ 8.19-8.15 (m, 1H), 8.04–8.00 (m, 2,3'-pyrrolo[2,1-a]isoindole]-1'-carbonitrile (11): 2 mg (2%),
1H), 7.80–7.66 (m, 2H), 2.84 (dd, J = 3.3, 12.0 Hz, 1H), oily crystals; 1H NMR (CD3OD, 300 MHz) δ 7.70–7.65 (m,
2.50–2.30 (m, 2H), 2.10–1.70 (m, 8H), 1.55–1.35 (m, 2H); 13C 2H), 7.59 (d, J = 7.6 Hz, 1H), 7.53 (dt, J = 0.6, 7.4 Hz, 1H),
NMR (CD3OD, 75 MHz) δ 202.5 (s, 1C), 134.9 (s, 1C), 134.7 4.03 (d, J = 7.9 Hz, 1H), 2.30–2.26 (m, 1H), 2.04–2.00 (m, 1H),
(d, 1C), 133.4 (d, 1C), 132.9 (d, 1C), 130.6 (d, 1C), 120.7 (s, 1.97–1.91 (m, 5H), 1.89–1.85 (m, 3H), 1.80–1.76 (m, 1H); 13C
1C, CN), 62.0 (d, 1C), 36.1 (t, 1C), 35.7 (t, 1C), 30.7 (s, 1C), NMR (CD3OD, 75 MHz) δ 208.6 (s, 1C), 135.4 (s, 1C), 134.7
1302